worldwiki
informational

What conditions can stem cell therapy treat?

Published Sep 18, 2026Updated Sep 19, 2026Last verified Sep 18, 2026Requests recorded in this site’s own server logs, with the crawler identity checked by reverse DNS or IP range.Google9Yandex1First collected Sep 18, 2026Recent requestsGoogleSep 20, 2026GoogleSep 20, 2026GoogleSep 20, 2026GoogleSep 19, 2026GoogleSep 19, 2026GoogleSep 19, 2026GoogleSep 19, 2026GoogleSep 19, 2026GoogleSep 18, 2026YandexSep 18, 2026
Request a correction
LanguagesEnglishWritten for this market; it is not a translation of another page.
Quick answer

Proven uses are mainly blood and immune system disorders. These are treated with hematopoietic stem cell transplantation, which has been used for more than 50 years, mostly for lymphomas, myeloma and leukemias. Stem cells are also used in some skin and cornea grafts. Regulators have approved a few other products for narrow indications, such as limbal stem cell deficiency in the EU and ALS or knee osteoarthritis in South Korea. Other uses remain experimental.

74 words10 sources

Answer

In 2016, lymphoproliferative disorders made up 53.0% of HSCTs worldwide and leukemias 35.7%.[3] The FDA states that regenerative products are not approved for conditions such as autism, Alzheimer's disease, Parkinson's disease or orthopedic conditions.[1]

Sources

  1. governmentImportant Patient and Consumer Information About Regenerative Medicine Therapies — U.S. Food and Drug Administration · accessed Sep 19, 2026 · Evidence page
  2. governmentApproved Cellular and Gene Therapy Products — U.S. Food and Drug Administration · accessed Sep 19, 2026 · Evidence page
  3. journalOne and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors (Niederwieser D, et al., Haematologica 107(5):1045-1053) — Haematologica · accessed Sep 20, 2026 · Evidence page
  4. organizationStem Cell Resources for Patients — International Society for Stem Cell Research (ISSCR) · accessed Sep 20, 2026 · Evidence page
  5. governmentGraft-versus-host disease: MedlinePlus Medical Encyclopedia — U.S. National Library of Medicine (MedlinePlus) · accessed Sep 20, 2026 · Evidence page
  6. journalMesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World (Fernández-Garza LE, et al., Pharmaceuticals 16(9):1334) — Pharmaceuticals (MDPI) · accessed Sep 20, 2026 · Evidence page
  7. governmentAlofisel: EPAR — European Medicines Agency · accessed Sep 20, 2026 · Evidence page
  8. organizationFDA Approves Remestemcel-L-Rknd for Steroid-Refractory Acute Graft-Versus-Host Disease in Pediatric Patients — Oncology Nursing Society · accessed Sep 20, 2026 · Evidence page
  9. journalNew legal category of 'advanced regenerative medicine treatment' in Korea's amended regenerative medicine law: comparative lessons from Japan (Yoon, Lee, Kim) — Stem Cell Reports · accessed Sep 20, 2026 · Evidence page
  10. journalUnproven stem cell therapy for macular degeneration (Ansari ZA, Kuriyan AE, Albini TA) — Oncotarget · accessed Sep 20, 2026 · Evidence page